- Home
- ELA vs GALT Comparison
ELA vs GALT Comparison
Compare ELA & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELA
- GALT
- Stock Information
- Founded
- ELA 1965
- GALT 2000
- Country
- ELA United States
- GALT United States
- Employees
- ELA N/A
- GALT N/A
- Industry
- ELA Consumer Specialties
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- ELA Consumer Discretionary
- GALT Health Care
- Exchange
- ELA Nasdaq
- GALT Nasdaq
- Market Cap
- ELA 197.1M
- GALT 232.3M
- IPO Year
- ELA N/A
- GALT N/A
- Fundamental
- Price
- ELA $10.48
- GALT $5.81
- Analyst Decision
- ELA Strong Buy
- GALT Strong Buy
- Analyst Count
- ELA 2
- GALT 3
- Target Price
- ELA $11.50
- GALT $6.00
- AVG Volume (30 Days)
- ELA 78.6K
- GALT 426.2K
- Earning Date
- ELA 11-05-2025
- GALT 11-14-2025
- Dividend Yield
- ELA N/A
- GALT N/A
- EPS Growth
- ELA 58.79
- GALT N/A
- EPS
- ELA 0.39
- GALT N/A
- Revenue
- ELA $208,843,961.00
- GALT N/A
- Revenue This Year
- ELA $14.43
- GALT N/A
- Revenue Next Year
- ELA $2.60
- GALT N/A
- P/E Ratio
- ELA $26.86
- GALT N/A
- Revenue Growth
- ELA 23.18
- GALT N/A
- 52 Week Low
- ELA $5.10
- GALT $0.73
- 52 Week High
- ELA $11.35
- GALT $6.55
- Technical
- Relative Strength Index (RSI)
- ELA 62.73
- GALT 57.06
- Support Level
- ELA $10.01
- GALT $5.59
- Resistance Level
- ELA $11.35
- GALT $6.32
- Average True Range (ATR)
- ELA 0.57
- GALT 0.57
- MACD
- ELA -0.02
- GALT 0.02
- Stochastic Oscillator
- ELA 64.96
- GALT 59.06
About ELA Envela Corporation
Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.